loadpatents
name:-0.0079450607299805
name:-0.0077991485595703
name:-0.0005340576171875
Bourdrez; Xavier Marc Patent Filings

Bourdrez; Xavier Marc

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bourdrez; Xavier Marc.The latest application filed is for "substituted pyridine-piperazinyl analogues as rsv antiviral compounds".

Company Profile
0.7.7
  • Bourdrez; Xavier Marc - Louviers FR
  • BOURDREZ; Xavier MARC - US
  • Bourdrez; Xavier Marc - Le Vadreuil FR
  • Bourdrez; Xavier Marc - Saint Pierre du Vauvray FR
  • Bourdrez; Xavier Marc - Le Vaudreuil FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Substituted pyridine-piperazinyl analogues as RSV antiviral compounds
Grant 10,150,761 - Guillemont , et al. Dec
2018-12-11
Substituted Pyridine-piperazinyl Analogues As Rsv Antiviral Compounds
App 20170291891 - GUILLEMONT; Jerome Emile Georges ;   et al.
2017-10-12
Substituted Pyridine-piperazinyl Analogues As Rsv Antiviral Compounds
App 20160168124 - GUILLEMONT; Jerome Emile Georges ;   et al.
2016-06-16
Quinolinone derivatives as PARP and tank inhibitors
Grant 8,778,966 - Vialard , et al. July 15, 2
2014-07-15
Quinolinone Derivatives As Parp And Tank Inhibitors
App 20130018017 - VIALARD; Jorge Eduardo ;   et al.
2013-01-17
Quinolinone derivatives as PARP and TANK inhibitors
Grant 8,299,256 - Vialard , et al. October 30, 2
2012-10-30
Quinazolinone derivatives as tubulin polymerization inhibitors
Grant 8,168,644 - Freyne , et al. May 1, 2
2012-05-01
Quinazolinone Derivatives As Tubulin Polymerization Inhibitors
App 20110028433 - Freyne; Eddy Jean Edgard ;   et al.
2011-02-03
Quinolinone Derivatives As Parp And Tank Inhibitors
App 20100168065 - Vialard; Jorge Eduardo ;   et al.
2010-07-01
1,2-annelated quinoline derivatives
Grant 6,914,066 - Angibaud , et al. July 5, 2
2005-07-05
1,2-annelated quinoline derivatives
App 20030119843 - Angibaud, Patrick Rene ;   et al.
2003-06-26
1,2-annelated quinoline derivatives
Grant 6,458,800 - Angibaud , et al. October 1, 2
2002-10-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed